{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Chemosensitivity", "Daidzein", "ROS", "Synergistic", "c-Jun"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35813479", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.7150/ijbs.71870"], "Journal": {"ISSN": "1449-2288", "JournalIssue": {"Volume": "18", "Issue": "9", "PubDate": {"Year": "2022"}}, "Title": "International journal of biological sciences", "ISOAbbreviation": "Int J Biol Sci"}, "ArticleTitle": "Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity.", "Pagination": {"StartPage": "3636", "EndPage": "3652", "MedlinePgn": "3636-3652"}, "Abstract": {"AbstractText": ["Lung cancer is the major cause of cancer associated mortality. Mutations in EGFR have been implicated in lung cancer pathogenesis. Gefitinib (GF) is a RTKI (receptor tyrosine kinase inhibitor) first-choice drug for EGFR mutated advanced lung cancer. However, drug toxicity and cancer cell resistance lead to treatment failure. Consequently, new therapeutic strategies are urgently required. Therefore, this study was aimed at identifying tumor suppressive compounds that can synergistically improve Gefitinib chemosensitivity in the lung cancer treatment. Medicinal plants offer a vast platform for the development of novel anticancer agents. Daidzein (DZ) is an isoflavone compound extracted from soy plants and has been shown to possess many medicinal benefits. The anticancer potential of GF and DZ combination treatment was investigated using MTT, western blot, fluorescent microscopy imaging, flow cytometry and nude mice tumor xenograft techniques. Our results demonstrate that DZ synergistically induces c-Jun nuclear translocation through ROS/ASK1/JNK and downregulates EGFR-STAT/AKT/ERK pathways to activate apoptosis and a G0/G1 phase cell cycle blockade. In in-vivo, the combination treatment significantly suppressed A549 lung cancer cells tumor xenograft growth without noticeable toxicity. Daidzein supplements with current chemotherapeutic agents may well be an alternative strategy to improve the treatment efficacy of lung adenocarcinoma."], "CopyrightInformation": "\u00a9 The author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan."}], "LastName": "Mhone", "ForeName": "Thomas Gabriel", "Initials": "TG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan."}, {"Identifier": [], "Affiliation": "Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan."}], "LastName": "Chen", "ForeName": "Ming-Cheng", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Exercise Biochemistry, University of Taipei, Taipei, Taiwan."}], "LastName": "Kuo", "ForeName": "Chia-Hua", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Imaging & Radiological Science College of Medicine, China Medical University, Taichung 404, Taiwan."}], "LastName": "Shih", "ForeName": "Tzu-Ching", "Initials": "TC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Changhua Christian Hospital, Changhua 500, Taiwan."}], "LastName": "Yeh", "ForeName": "Chung-Min", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan."}, {"Identifier": [], "Affiliation": "School of Medicine Tzu Chi University, 701, Section 3, Chung-Yang Road, Hualien 97004, Taiwan."}], "LastName": "Wang", "ForeName": "Tso-Fu", "Initials": "TF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan."}], "LastName": "Chen", "ForeName": "Ray-Jade", "Initials": "RJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan."}], "LastName": "Chang", "ForeName": "Yu-Chun", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science and Technology, China Medical University, Taichung 406, Taiwan."}, {"Identifier": [], "Affiliation": "Ph.D. Program for Biotechnology Industry, China Medical University, Taichung 406, Taiwan."}], "LastName": "Kuo", "ForeName": "Wei-Wen", "Initials": "WW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan."}, {"Identifier": [], "Affiliation": "Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan."}, {"Identifier": [], "Affiliation": "Center of General Education, Buddhist Tzu Chi Medical Foundation, Tzu Chi University of Science and Technology, Hualien 970, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Asia University, Taichung 413, Taiwan."}], "LastName": "Huang", "ForeName": "Chih-Yang", "Initials": "CY"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Int J Biol Sci", "NlmUniqueID": "101235568", "ISSNLinking": "1449-2288"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "6287WC5J2L", "NameOfSubstance": "daidzein"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "EGFR protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ErbB Receptors"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "S65743JHBS", "NameOfSubstance": "Gefitinib"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Adenocarcinoma of Lung"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["genetics"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["genetics"], "DescriptorName": "ErbB Receptors"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Gefitinib"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Isoflavones"}, {"QualifierName": ["genetics"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "Competing Interests: The authors have declared that no competing interest exists."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Siegel R. L, Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA. Cancer J. Clin. 2020;70:7\u201330.", "ArticleIdList": ["31912902"]}, {"Citation": "Lu T. et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag. Res. 2019;11:943\u2013953.", "ArticleIdList": ["PMC6345192", "30718965"]}, {"Citation": "Barta J. A, Powell, C. A. & Wisnivesky, J. P. Global epidemiology of lung cancer. Annals of Global Health. 2019. 85.", "ArticleIdList": ["PMC6724220", "30741509"]}, {"Citation": "Gaur P. et al. EGFR Mutation Detection and Its Association With Clinicopathological Characters of Lung Cancer Patients. World J. Oncol. 2018;9:151\u2013155.", "ArticleIdList": ["PMC6279455", "30524640"]}, {"Citation": "Zhang Y. et al. Are exon 19 deletions and L858R different in early stage lung adenocarcinoma? J. Cancer Res. Clin. Oncol. 2018;144:165\u2013171.", "ArticleIdList": ["29026990"]}, {"Citation": "Wu L, Ke L, Zhang Z, Yu J. & Meng, X. Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors. Front. Oncol. 2020;10:2778.", "ArticleIdList": ["PMC7775519", "33392095"]}, {"Citation": "Redza-Dutordoir M. & Averill-Bates, D. A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta - Molecular Cell Research. 2016;1863:2977\u20132992.", "ArticleIdList": ["27646922"]}, {"Citation": "Meijles D. N. et al. Redox regulation of cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) controls p38-MAPK (Mitogen-Activated Protein Kinase) and orchestrates cardiac remodeling to hypertension. Hypertension. 2020. pp. 1208\u20131218.", "ArticleIdList": ["PMC7480944", "32903101"]}, {"Citation": "Guo S. et al. Daidzein-rich isoflavones aglycone inhibits lung cancer growth through inhibition of NF-\u03baB signaling pathway. Immunol. Lett. 2020;222:67\u201372.", "ArticleIdList": ["32197974"]}, {"Citation": "HE Y. et al. Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway. Neoplasma. 2016;63:523\u2013531.", "ArticleIdList": ["27268915"]}, {"Citation": "Han B. J. et al. Effects of daidzein in regards to cytotoxicity in vitro, apoptosis, reactive oxygen species level, cell cycle arrest and the expression of caspase and Bcl-2 family proteins. Oncol. Rep. 2015;34:1115\u20131120.", "ArticleIdList": ["PMC4530929", "26178389"]}, {"Citation": "Dagdemir A, Durif J, Ngollo M, Bignon Y. J. & Bernard-Gallon, D. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Epigenomics. 2013;5:51\u201363.", "ArticleIdList": ["23414320"]}, {"Citation": "Jin S, Zhang Q. Y, Kang, X. M, Wang, J. X. & Zhao, W. H. Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol. 2010;21:263\u2013268.", "ArticleIdList": ["19889614"]}, {"Citation": "Charalambous C, Pitta C. A. & Constantinou, A. I. Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC Cancer. 2013;13:238.", "ArticleIdList": ["PMC3661348", "23675643"]}, {"Citation": "Hua F, Li C. H, Chen, X. G. & Liu, X. P. Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade. Int. J. Mol. Med. 2018;41:3485\u20133492.", "ArticleIdList": ["29512690"]}, {"Citation": "Liu S. P. et al. Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1\u03b1 induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis. Nutr. Metab. 2020;17:1\u20139.", "ArticleIdList": ["PMC6995207", "32021640"]}, {"Citation": "Liu Y. S. et al. Inhibition of Protein Phosphatase 1 Stimulates Noncanonical ER Stress eIF2\u03b1 Activation to Enhance Fisetin-induced Chemosensitivity in HDAC Inhibitor-resistant Hepatocellular Carcinoma Cells. Cancers. 2019;11:918.", "ArticleIdList": ["PMC7692598", "33153241"]}, {"Citation": "Hsu HH, Chen MC, Baskaran R. et al. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol. 2018;233(7):5458\u20135467.", "ArticleIdList": ["29247488"]}, {"Citation": "Chang W. S. et al. Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9. J. Food Biochem. 2021;45:e13666.", "ArticleIdList": ["34008860"]}, {"Citation": "Chen YF, Chang WH, Tsai HY, Lee MM, Wu TS. Bioactivities and action mechanisms of active compounds from Hottuynia cordata THUNB on human lung cancer cells. Biomed. 2021;11(2):40\u20136.", "ArticleIdList": ["PMC8824244", "35223403"]}, {"Citation": "Lin C.-Y. et al. WISP-3 Stimulates VEGF-C-Dependent Lymphangiogenesis in Human Chondrosarcoma Cells by Inhibiting miR-196a-3p Synthesis. Biomed. 2021;9:1330.", "ArticleIdList": ["PMC8533311", "34680447"]}, {"Citation": "Hsu HH, Kuo WW, Shih HN, Cheng SF, Yang CK, Chen MC. et al. FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer. Cancers. 2019;11(10):1576.", "ArticleIdList": ["PMC6827018", "31623173"]}, {"Citation": "Jeng L Bin, Kumar Velmurugan B, Chen MC, Hsu HH, Ho TJ, Day CH. et al. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo. J Cell Physiol. 2018;233(9):7134\u201342.", "ArticleIdList": ["29574877"]}, {"Citation": "Huang T. Y. et al. Combinational treatment of all-trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)-induced apoptosis in liver cancer Hep3B cells. J. Food Biochem. 2020. 44.", "ArticleIdList": ["31837044"]}, {"Citation": "Jensen M. M, J\u00f8rgensen, J. T, Binderup, T. & Kj\u00e6r, A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med. Imaging. 2008;8:16.", "ArticleIdList": ["PMC2575188", "18925932"]}, {"Citation": "Zhang Q. et al. Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer. Oncotarget. 2017;8:72447.", "ArticleIdList": ["PMC5641144", "29069801"]}, {"Citation": "Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27.", "ArticleIdList": ["PMC4804402", "27057123"]}, {"Citation": "Threatt S. D, Synold, T. W, Wu, J. & Barton, J. K. In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model. Proc. Natl. Acad. Sci. U. S. A. 2020;117:17535\u201317542.", "ArticleIdList": ["PMC7395490", "32661159"]}, {"Citation": "Lin W. C. et al. Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma-bearing mouse model. Oncol. Rep. 2018;40:1390\u20131400.", "ArticleIdList": ["PMC6072404", "30015952"]}, {"Citation": "Gao Y, Chen DL, Zhou M. et al. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. Cell Death Dis. 2020;11(10):1\u201312.", "ArticleIdList": ["PMC7567864", "33067427"]}, {"Citation": "Chang Y. S, Choi, C. M. & Lee, J. C. Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma. Tuberc. Respir. Dis. (Seoul) 2016;79:248\u2013256.", "ArticleIdList": ["PMC5077728", "27790276"]}, {"Citation": "Schuster-Gaul S. et al. ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. JCI Insight. 2020. 5.", "ArticleIdList": ["PMC7098717", "31996485"]}, {"Citation": "Zheng W. et al. Daidzein induces choriocarcinoma cell apoptosis in a dose-dependent manner via the mitochondrial apoptotic pathway. Mol. Med. Rep. 2018;17:6093\u20136099.", "ArticleIdList": ["29436666"]}, {"Citation": "Kaushik S, Shyam H, Sharma R. & Balapure, A. K. Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells. Phytomedicine. 2018;40:116\u2013124.", "ArticleIdList": ["29496164"]}, {"Citation": "V K. & SS, C. Daidzein Induces Intrinsic Pathway of Apoptosis along with ER \u03b1/\u03b2 Ratio Alteration and ROS Production. Asian Pac. J. Cancer Prev. 2021;22:603\u2013610.", "ArticleIdList": ["PMC8190374", "33639680"]}, {"Citation": "Tang S. et al. Daidzein Induced Apoptosis via Down-Regulation of Bcl-2/Bax and Triggering of the Mitochondrial Pathway in BGC-823 Cells. Cell Biochem. Biophys. 2013;65:197\u2013202.", "ArticleIdList": ["22926545"]}, {"Citation": "Yan G, Elbadawi M. & Efferth, T. Multiple cell death modalities and their key features (Review). World Acad. Sci. J. 2020;2:39\u201348."}, {"Citation": "Xie C, Yi J, Lu J, N-Acetylcysteine reduces ROS-mediated oxidative DNA damage and PI3K/Akt pathway activation induced by Helicobacter pylori infection. Oxid Med Cell Longev. 2018. 2018.", "ArticleIdList": ["PMC5944265", "29854076"]}, {"Citation": "Zhao Q. et al. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo. Cell Death Discov. 2019;5:125.", "ArticleIdList": ["PMC6680048", "31396402"]}, {"Citation": "Huang G, Xu J. & Guo, T. L. Isoflavone daidzein regulates immune responses in the B6C3F1 and non-obese diabetic (NOD) mice. Int. Immunopharmacol. 2019;71:277\u2013284.", "ArticleIdList": ["PMC6529284", "30927738"]}, {"Citation": "Feng G, Sun B. & Li, T. Z. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. Int. Immunopharmacol. 2015;26:392\u2013400.", "ArticleIdList": ["25887269"]}, {"Citation": "Yu Z, Yang L, Deng S. & Liang, M. Daidzein ameliorates LPS-induced hepatocyte injury by inhibiting inflammation and oxidative stress. Eur. J. Pharmacol. 2020. 885.", "ArticleIdList": ["32712091"]}, {"Citation": "Huang G, Xu J. & Guo, T. L. Isoflavone daidzein regulates immune responses in the B6C3F1 and non-obese diabetic (NOD) mice. Int. Immunopharmacol. 2019;71:277\u2013284.", "ArticleIdList": ["PMC6529284", "30927738"]}, {"Citation": "Zhou D. R. et al. Intracellular second messengers mediate stress inducible hormesis and Programmed Cell Death: A review. Biochim. Biophys. Acta - Mol. Cell Res. 2019;1866:773\u2013792.", "ArticleIdList": ["30716408"]}, {"Citation": "Tang D, Kang R, Berghe T. Vanden, Vandenabeele, P. & Kroemer, G. The molecular machinery of regulated cell death. Cell Res. 2019;29(5):347\u2013364.", "ArticleIdList": ["PMC6796845", "30948788"]}, {"Citation": "R Singh, A. L. K. S. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175\u2013193.", "ArticleIdList": ["PMC7325303", "30655609"]}, {"Citation": "Dai Y. et al. The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer. Oncotarget. 2016;8:1354\u20131368.", "ArticleIdList": ["PMC5352061", "27935869"]}, {"Citation": "Chattopadhyay A, Chiang C.-W. & Yang, E. BAD/BCL-xL heterodimerization leads to bypass of G0/G1 arrest. Oncogene. 2001;20(33):4507\u20134518.", "ArticleIdList": ["11494146"]}, {"Citation": "Datta SR, Dudek H, Xu T, Masters S, Haian F, Gotoh Y. et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery. Cell. 1997;91(2):231\u201341.", "ArticleIdList": ["9346240"]}, {"Citation": "Ding L. et al. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. Int. J. Mol. Sci. 2020. 21.", "ArticleIdList": ["PMC7139603", "32183020"]}, {"Citation": "Abbastabar M. et al. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein. DNA Repair (Amst) 2018;69:63\u201372.", "ArticleIdList": ["30075372"]}, {"Citation": "Lamartiniere C. A, Wang, J, Smith-Johnson, M. & Eltoum, I. E. Daidzein: Bioavailability, Potential for Reproductive Toxicity, and Breast Cancer Chemoprevention in Female Rats. Toxicol. Sci. 2002;65:228\u2013238.", "ArticleIdList": ["11812927"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "9"}, {"Year": "2022", "Month": "4", "Day": "24"}, {"Year": "2022", "Month": "7", "Day": "11", "Hour": "4", "Minute": "2"}, {"Year": "2022", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35813479", "PMC9254481", "10.7150/ijbs.71870", "ijbsv18p3636"]}}], "PubmedBookArticle": []}